Government price setting policies like Most Favored Nation are a bad deal for American patients. The “Foreign First Pricing” ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Tremfya (guselkumab) (Tremfya) to treat Crohn’s disease and ulcerative colitis (UC).